Other Clinical Trial - Cell Marker Predictors in Barrett's Esophagus

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Status Active, not recruiting

Clinical Trial Summary

The purpose of this study is to analyze biopsied tissue samples for changes in cells and genes involved in Barrett's Esophagus.

Patients with a history of Barrett's esophagus who are scheduled for a routine endoscopy will have an additional biopsy taken for genetic testing. ;

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06071845` - Assessment of a Minimally Invasive Collection Device for Molecular Analysis of Esophageal Samples	N/A
Not yet recruiting	`NCT05745857` - Oral Bevacizumab-800CW and Cetuximab-800CW Administration to Detect Early Esophageal Adenocarcinomas	Phase 2
Recruiting	`NCT04295811` - Efficacy of EsoGuard Assay on Esophageal Surface Cells Collected With EsoCheck vs EGD for the Diagnosis of BE or EAC	N/A
Completed	`NCT03814824` - Volumetric Laser Endomicroscopy With Intelligent Real-time Image Segmentation (IRIS)	N/A
Enrolling by invitation	`NCT04561791` - Evaluation of Tethered Capsule Endomicroscopy as a Screening Tool for Barrett's Esophagus in the Primary Care Setting	N/A
Completed	`NCT04293458` - Efficacy of EsoGuard on Samples Collected Using EsoCheck Versus EGD for the Diagnosis of BE	N/A
Completed	`NCT06381583` - A Liquid Biopsy for High-risk Pre-cancer Screening of Esophageal Adenocarcinoma
Recruiting	`NCT05965999` - Lucid Registry Study